دورية أكاديمية
أعرض في EDS

High prevalence of zero-dose children in underserved and special setting populations in Ethiopia using a generalize estimating equation and concentration index analysis.

التفاصيل البيبلوغرافية
العنوان: High prevalence of zero-dose children in underserved and special setting populations in Ethiopia using a generalize estimating equation and concentration index analysis.
المؤلفون: Biks GA; Project HOPE, Ethiopia Country Office, Addis Ababa, Ethiopia. Gandargie@projecthope.org., Shiferie F; Project HOPE, Ethiopia Country Office, Addis Ababa, Ethiopia., Tsegaye DA; Project HOPE, Ethiopia Country Office, Addis Ababa, Ethiopia., Asefa W; Project HOPE Headquarter, Washington, D.C, USA., Alemayehu L; Project HOPE, Ethiopia Country Office, Addis Ababa, Ethiopia., Wondie T; Project HOPE, Ethiopia Country Office, Addis Ababa, Ethiopia., Zelalem M; Maternal and Child Health, Minister of Health, Addis Ababa, Ethiopia., Lakew Y; Maternal and Child Health, Minister of Health, Addis Ababa, Ethiopia., Belete K; USAID, Addis Ababa, Ethiopia., Gebremedhin S; School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
المصدر: BMC public health [BMC Public Health] 2024 Feb 23; Vol. 24 (1), pp. 592. Date of Electronic Publication: 2024 Feb 23.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2001-
مواضيع طبية MeSH: Mothers* , Prenatal Care*, Child ; Female ; Humans ; Pregnancy ; Ethiopia/epidemiology ; Cross-Sectional Studies ; Prevalence
مستخلص: Background: Globally, according to the World Health Organization (WHO) 2023 report, more than 14.3 million children in low- and middle-income countries, primarily in Africa and South-East Asia, are not receiving any vaccinations. Ethiopia is one of the top ten countries contributing to the global number of zero-dose children.
Objective: To estimate the prevalence of zero-dose children and associated factors in underserved populations of Ethiopia.
Methods: A cross-sectional vaccine coverage survey was conducted in June 2022. The study participants were mothers of children aged 12-35 months. Data were collected using the CommCare application system and later analysed using Stata version 17. Vaccination coverage was estimated using a weighted analysis approach. A generalized estimating equation model was fitted to determine the predictors of zero-dose children. An adjusted odds ratio (AOR) with 95% confidence interval (CI) and a p-value of 0.05 or less was considered statistically significant.
Results: The overall prevalence of zero-dose children in the study settings was 33.7% (95% CI: 34.9%, 75.7%). Developing and pastoralist regions, internally displaced peoples, newly formed regions, and conflict-affected areas had the highest prevalence of zero-dose children. Wealth index (poorest [AOR = 2.78; 95% CI: 1.70, 4.53], poorer [AOR = 1.96; 95% CI: 1.02, 3.77]), single marital status [AOR = 2.4; 95% CI: 1.7, 3.3], and maternal age (15-24 years) [AOR = 1.2; 95% CI: 1.1, 1.3] were identified as key determinant factors of zero-dose children in the study settings. Additional factors included fewer than four Antenatal care visits (ANC) [AOR = 1.3; 95% CI: 1.2, 1.4], not receiving Postnatal Care (PNC) services [AOR = 2.1; 95% CI: 1.5, 3.0], unavailability of health facilities within the village [AOR = 3.7; 95% CI: 2.6, 5.4], women-headed household [AOR = 1.3; 95% CI:1.02, 1.7], low gender empowerment [AOR = 1.6; 95% CI: 1.3, 2.1], and medium gender empowerment [AOR = 1.7; 95% CI: 1.2, 2.5].
Conclusion: In the study settings, the prevalence of zero-dose children is very high. Poor economic status, disempowerment of women, being unmarried, young maternal age, and underutilizing antenatal or post-natal services are the important predictors. Therefore, it is recommended to target tailored integrated and context-specific service delivery approach. Moreover, extend immunization sessions opening hours during the evening/weekend in the city administrations to meet parents' needs.
(© 2024. The Author(s).)
References: PLOS Glob Public Health. 2022 Apr 27;2(4):e0000244. (PMID: 36962232)
BMC Public Health. 2020 Dec 1;20(1):1837. (PMID: 33256701)
Matern Child Health J. 2021 Jan;25(1):95-106. (PMID: 33226578)
Pan Afr Med J. 2017 Apr 24;26:220. (PMID: 28690734)
Int J Equity Health. 2020 May 12;19(1):65. (PMID: 32398089)
BMC Public Health. 2020 Sep 7;20(1):1365. (PMID: 32894099)
BMC Health Serv Res. 2019 Aug 30;19(1):614. (PMID: 31470849)
PLoS One. 2019 Mar 29;14(3):e0213896. (PMID: 30925153)
Ital J Pediatr. 2020 Mar 4;46(1):28. (PMID: 32131868)
BMC Public Health. 2008 Nov 12;8:386. (PMID: 19014485)
PLoS One. 2020 Jul 20;15(7):e0235825. (PMID: 32687506)
Vaccines (Basel). 2022 Jun 30;10(7):. (PMID: 35891216)
BMC Public Health. 2020 Jan 29;20(1):123. (PMID: 31996184)
BMJ Glob Health. 2022 May;7(5):. (PMID: 35577393)
Vaccines (Basel). 2022 Jun 27;10(7):. (PMID: 35891196)
Front Public Health. 2022 Oct 25;10:977512. (PMID: 36388274)
BMC Public Health. 2020 Nov 26;20(1):1803. (PMID: 33243208)
J Womens Health (Larchmt). 2018 Feb;27(2):196-202. (PMID: 28832241)
PLOS Glob Public Health. 2022 Oct 26;2(10):e0001126. (PMID: 36962682)
Int J Pediatr. 2019 May 27;2019:1924941. (PMID: 31263502)
Hum Vaccin Immunother. 2020 May 3;16(5):1202-1207. (PMID: 31545118)
Vaccine. 2021 Jul 22;39(32):4564-4570. (PMID: 33744046)
BMC Public Health. 2008 May 16;8:161. (PMID: 18485194)
BMC Public Health. 2014 Mar 06;14:232. (PMID: 24602264)
Soc Sci Med. 2012 Jul;75(2):384-91. (PMID: 22571892)
Philos Trans A Math Phys Eng Sci. 2016 Apr 13;374(2065):20150202. (PMID: 26953178)
Vaccine. 2020 Apr 29;38(20):3627-3638. (PMID: 32253099)
PLoS One. 2019 Nov 20;14(11):e0225374. (PMID: 31747437)
SSM Popul Health. 2021 Aug 05;15:100888. (PMID: 34430700)
Vaccines (Basel). 2023 Mar 31;11(4):. (PMID: 37112693)
Vaccine. 2023 Jan 4;41(1):170-181. (PMID: 36414476)
BMC Public Health. 2016 Jan 12;16:27. (PMID: 26757893)
Lancet. 2021 Aug 7;398(10299):522-534. (PMID: 34273292)
BMC Public Health. 2022 Jan 27;22(1):183. (PMID: 35086495)
Vaccines (Basel). 2021 Jun 13;9(6):. (PMID: 34199179)
Health Res Policy Syst. 2019 Jan 9;17(1):2. (PMID: 30626379)
PLoS One. 2010 Jun 23;5(6):e11190. (PMID: 20585646)
BMC Infect Dis. 2022 May 2;22(1):421. (PMID: 35501702)
Soc Sci Med. 2018 Sep;213:63-71. (PMID: 30059899)
PLoS One. 2020 Aug 7;15(8):e0236955. (PMID: 32764770)
BMC Pediatr. 2019 Jun 14;19(1):198. (PMID: 31200690)
Hum Vaccin Immunother. 2020 May 3;16(5):1215-1220. (PMID: 31634047)
Am J Prev Med. 2021 Jan;60(1 Suppl 1):S24-S33. (PMID: 33131990)
J Epidemiol Community Health. 2012 Oct;66(10):934-41. (PMID: 22268129)
PLoS One. 2018 Oct 31;13(10):e0206766. (PMID: 30379947)
J Health Econ. 2013 May;32(3):659-70. (PMID: 23522656)
Vaccines (Basel). 2022 Jun 21;10(7):. (PMID: 35891152)
Nagoya J Med Sci. 2017 Feb;79(2):179-188. (PMID: 28626253)
BMC Res Notes. 2015 Jun 13;8:239. (PMID: 26071403)
BMC Health Serv Res. 2018 Jul 18;18(1):564. (PMID: 30021571)
Public Health Nutr. 2022 Feb;25(2):257-268. (PMID: 34615568)
J Health Popul Nutr. 2018 Oct 22;37(1):22. (PMID: 30348219)
Cien Saude Colet. 2022 Feb;27(2):793-802. (PMID: 35137833)
Stata J. 2016 1st Quarter;16(1):112-138. (PMID: 27053927)
معلومات مُعتمدة: NV 018567 Bill and Melinda Gates Foundation; NV 018567 Bill and Melinda Gates Foundation; NV 018567 Bill and Melinda Gates Foundation; NV 018567 Bill and Melinda Gates Foundation; NV 018567 Bill and Melinda Gates Foundation; NV 018567 Bill and Melinda Gates Foundation; NV 018567 Bill and Melinda Gates Foundation; NV 018567 Bill and Melinda Gates Foundation; NV 018567 Bill and Melinda Gates Foundation; NV 018567 Bill and Melinda Gates Foundation
فهرسة مساهمة: Keywords: 12–35 months children; Developing regions; GEE generalized estimating equation; Hard-to-reach underserved settings; Pastoralist; Zero-dose coverage
تواريخ الأحداث: Date Created: 20240223 Date Completed: 20240226 Latest Revision: 20240227
رمز التحديث: 20240227
مُعرف محوري في PubMed: PMC10893596
DOI: 10.1186/s12889-024-18077-w
PMID: 38395877
قاعدة البيانات: MEDLINE
الوصف
تدمد:1471-2458
DOI:10.1186/s12889-024-18077-w